Global Blood Glucose Device Market is expected to surpass US$ 25 Billion mark by the end of the year 2025
27 Nov, 2019

“Blood Glucose Device Market, Users Global Forecast, SMBG Components (Test Strips, Lancet, Meter) of 17 Countries (USA, Europe, Asia & Pacific, Middle East & Africa) & Companies (Roche, LifeScan Inc. HealthCare, Abbott)” analyzes the worldwide market for, blood glucose test strips, lancet and meter market. This is the 5th publication on Blood Glucose Device Market by Renub Research. Global Blood Glucose Device Market is expected to surpass US$ 25 Billion mark by the end of the year 2025.

There are some factors which are helping the global SMBG market to outperform; increasing per capita healthcare expenditure, government widening their reimbursement policies regarding SMBG, several non-government diabetes associations’ assisting financial support for so many patients based on severe condition. Advancement of technology, increasing private insurance coverage, people awareness regarding use of SMBG device, increasing overall diabetes population across the world, people with type 1 diabetes faces severe complication in day to day life etc.

This report covers three main SMBG products like test-strips, lancet, and glucose meter. Currently type 1 diabetes patients using this device mostly but in future course of time type 2 diabetes patients is expected to use it more because type 1 diabetes patients patent are shifting towards CGM device for continuous real time monitoring of glucose.

Request a free Brochure copy of the report:  https://www.renub.com/request-brochure-page.php?gturl=blood-glucose-device-market-and-forecast-smbg-test-strips-lancet-meter-worldwide-analysis-977-p.php

Market Summary:

By Types of Diabetes: this report provides complete information of overall diabetes population, type 1 diabetes population, type 2 diabetes population. In addition blood glucose devices market is also fragmented into type1 diabetes market and type 2 diabetes market. We have done extensive study of SMBG consumer in the report; their rate of use of test-strips, their demand and how many numbers of people using it. 

By Device type:  here the blood glucose device fragmented into three part test-strips, lancet and glucose meter. In addition report also covers frequency of device used in daily, weekly and monthly basis.

By Country: this report covers multi-dimensional information regarding blood glucose device of leading top 17 countries along with growth factors and challenges faced by each countries. The prevalence of diabetes in China has grown rapidly, becoming one of the world's largest diabetes countries. About 116.8 million people in China have been affected by diabetes, but the incidence of SMBG users in China has been quite low compared to developed countries. 

If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.

Key Topics Covered :

1.    Introduction
2.    Research Methodology

3.    Executive Summary
4.    Growth Factors for Blood Glucose Devices

4.1    Point No. 1
4.2    Point No. 2
4.3    Point No. 3
4.4    Point No. 4

5.    Challenges of Blood Glucose Devices Market

5.1    Point no. 1
5.2    Point No. 2

6.    Global Blood Glucose (SMBG) Market and Users

6.1    Blood Glucose Device Market (Type1 + Type 2) Diabetes
6.2    Test Strips Market and Forecast
6.3    Lancet Market and Forecast
6.4    Meter Market and Forecast
6.5    Global Diabetes Population (Type1 + Type 2)
6.6    Blood Glucose (SMBG) Device Users (Type1 + Type 2)

7.    Share Analysis – Blood Glucose Device Market, Diabetes Population, SMBG User & Company

7.1    SMBG Market Share
7.2    Diabetes Population Share
7.3    Blood Glucose Device User Share & Forecast
7.4    Companies Share

8.    United States

8.1    United States Diabetes Population (2011 – 2025)
8.2    Blood Glucose Device (SMBG) Market
8.3    Blood Glucose (SMBG) Users and Forecast
8.4    Reimbursement of Blood Glucose Devices in United States

9.    United Kingdom

9.1    United Kingdom Diabetes Population(2011 – 2025)
9.2    Blood Glucose Device (SMBG) Market and Forecast
9.3    Blood Glucose Device (SMBG) Users and Forecast
9.4    Reimbursement of Blood Glucose Devices in United Kingdom

10.    Germany

10.1    Germany Diabetes Population(2011 – 2025)
10.2    Blood Glucose Devices (SMBG) Market (2011 – 2025)
10.3    Blood Glucose Devices (SMBG) Users (2011 – 2025)
10.4    Reimbursement of Blood Glucose Devices in Germany

11.    Spain

11.1    Spain Diabetes Population(2011 – 2025)
11.2    Blood Glucose Devices (SMBG) Market (2011 – 2025)
11.3    Blood Glucose Device (SMBG) Users and Forecast
11.4    Reimbursement of Blood Glucose Devices in Spain

12.    Italy

12.1    Italy Diabetes Population(2011 – 2025)
12.2    Blood Glucose (SMBG) Market (2011 – 2025)
12.3    Italy Self-Monitoring of Blood Glucose (SMBG) Users (2011 – 2025)
12.4    Reimbursement of Blood Glucose Devices in Italy

13.    Netherlands

13.1    Netherlands Diabetes Population(2011 – 2025)
13.2    Blood Glucose Devices (SMBG) Market (2011 – 2025)
13.3    Blood Glucose Devices (SMBG) Users and Forecast
13.4    Reimbursement of Blood Glucose Devices in Netherlands

14.    Norway

14.1    Norway Diabetes Population(2011 – 2025)
14.2    Blood Glucose Devices (SMBG) Market and Forecast
14.3    Blood Glucose Devices (SMBG) Users and Forecast
14.4    Reimbursement of Blood Glucose Devices in Norway

15.    Sweden

15.1    Sweden Diabetes Population(2011 – 2025)
15.2    Blood Glucose (SMBG) Market (2011 – 2025)
15.3    Blood Glucose Device (SMBG) Users and Forecast
15.4    Reimbursement of Blood Glucose Devices in Sweden

16.    Switzerland

16.1    Switzerland Diabetes Population(2011 – 2025)
16.2    Blood Glucose Devices (SMBG) Market (2011 – 2025)
16.3    Blood Glucose Devices (SMBG) Users and Forecast
16.4    Reimbursement of Blood Glucose Devices in Switzerland

17.    Russia

17.1    Russia Diabetes Population (2011 – 2025)
17.2    Blood Glucose (SMBG) Market (2011 – 2025)
17.3    Blood Glucose Devices (SMBG) Users and Forecast
17.4    Reimbursement of Blood Glucose Devices in Russia

18.    Brazil

18.1    Brazil Diabetes Population (2011 – 2025)
18.2    Blood Glucose Devices (SMBG) Market and Forecast
18.3    Blood Glucose Devices (SMBG) Users and Forecast
18.4    Reimbursement of Blood Glucose Devices in Brazil

19.    India

19.1    India Diabetes Population (2011 – 2025)
19.2    Blood Glucose Devices (SMBG) Market (2011 – 2025)
19.3    Blood Glucose Devices (SMBG) Users and Forecast

20.    China

20.1    China Diabetes Population (2011 – 2025)
20.2    Blood Glucose Devices (SMBG) Market and Forecast
20.3    Blood Glucose Devices (SMBG) Users (2011 – 2025)

21.    Australia

21.1    Australia Diabetes Population (2011 – 2025)
21.2    Blood Glucose Devices (SMBG) Market and Forecast
21.3    Blood Glucose Devices (SMBG) Users and Forecast
21.4    Reimbursement of Blood Glucose Devices in Australia

22.    Kuwait

22.1    Kuwait Diabetes Population (2011 – 2025)
22.2    Blood Glucose Devices (SMBG) Market and Forecast
22.3    Blood Glucose Devices (SMBG) Users (2011 – 2025)

23.    Saudi Arabia

23.1    Saudi Arabia Diabetes Population (2011 – 2025)
23.2    Blood Glucose Devices (SMBG) Market and Forecast
23.3    Blood Glucose Devices (SMBG) Users and Forecast
23.4    Reimbursement of Blood Glucose Devices in Saudi Arabia

24.    South Africa

24.1    South Africa Diabetes Population (2011 – 2025)
24.2    Blood Glucose Devices (SMBG) Market and Forecast
24.3    Blood Glucose Devices (SMBG) Users and Forecast

25.    Company Analysis

25.1    Roche Diagnostic
25.2    LifeScan Inc.
25.3    Abbott Laboratories

About Us

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us
Renub Research
Phone: +1-678-302-0700
Email: info@renub.com
Website: www.renub.com
Follow us on LinkedIn: www.linkedin.com/company/renub-research